儿科药学杂志2026，Vol.32Issue(2)：5-8,4.DOI:10.13407/j.cnki.jpp.1672-108X.2026.02.002
国家医保药品目录中儿童止咳平喘类中成药的组方规律
Formulation Rules of Pediatric Cough-Relieving and Asthma-Alleviating Chinese Patent Medicines in the National Reimbursement Drug List
摘要
Abstract
Objective:To analyze the compatibility patterns of pediatric cough-relieving and asthma-alleviating Chinese patent medicines listed in the Medicine List for National Basic Medical Insurance,Employment Injury Insurance and Maternity Insurance(2023 edition)(hereinafter referred to as"the National Reimbursement Drug List")based on data mining techniques.Methods:Pediatric-specific preparations in the National Reimbursement Drug List were screened.The medicinal efficacy,properties,flavors,and meridian tropisms were statistically analyzed.Association rule mining and cluster analysis were performed by using SPSS Modeler 18.0 and IBM SPSS 27.0.Results:Eighteen pediatric cough-relieving and asthma-alleviating Chinese patent medicines were enrolled,including 82 kinds of traditional Chinese medicines(180 times in total).High-frequency traditional Chinese medicines were respectively licorice(13 times),Amygdalus communis vas(12 times),Ephedra herba(10 times),and Gypsum fibrosum(10 times).Association rule analysis revealed that formulations were predominantly based on modification of Maxing Shigan decoction.Conclusion:Maxing Shigan decoction holds fundamental guiding significance for the formulation design of modern Chinese patent medicines targeting pediatric cough-relieving and asthma-alleviating.The mining results of core formulas have significant reference value for the screening of Chinese patent medicines prescriptions in medical institutions.关键词
数据挖掘/医保目录/止咳平喘/中成药/组方规律/麻杏石甘汤Key words
data mining/National Reimbursement Drug List/cough-relieving and asthma-alleviating/Chinese patent medicines/formulation rules/Maxing Shigan decoction分类
医药卫生引用本文复制引用
薛梦,丛小虎,隋营营,闫美兴,刘畅..国家医保药品目录中儿童止咳平喘类中成药的组方规律[J].儿科药学杂志,2026,32(2):5-8,4.基金项目
山东省医务职工科技创新计划项目(联合立项),编号SDYWZGKCJHLH202223. （联合立项）
